In 2000, 171 million people were estimated to have diabetes, and more than 5 million became blind owing to diabetic retinopathy (DR). This number is expected to double before 2030.1-3 Diabetic retinopathy is progressive change in vascular permeability and a proliferation of fragile, new retinal blood vessels.4-6 The duration of diabetes correlates with both DR and its severity.7,8 Even with optimal glucose control, nearly all diabetic persons will eventually develop DR.
Studies have demonstrated that early diagnosis and laser treatment of DR can prevent severe vision loss.9-11 Because DR has few symptoms until vision loss develops,12 regular DR screening is critical.3,13 Two recognized gold standards for DR screening are ophthalmological examination by a trained health professional (eg, ophthalmologist) using pupillary dilation (mydriasis) and stereoscopic 7-field fundus photography by a trained photographer with image interpretation by an experienced grader.4 Both methods require the specialist equipment and expertise of hospitals and specialist clinics.
Studies from Australia, the United States, and Spain show that only 50% to 60% of diabetic individuals are screened according to national guidelines.14-16 Diabetic persons who live in rural and/or remote parts of high-income countries and those who live in low- and middle-income countries have poorer access to specialist ophthalmological services and lower rates of screening for DR.13,17-19 Some populations have both high rates of diabetes and poor access to screening services. For example, 37% of indigenous adults in Australia have diabetes, 13% of whom have already progressed to diabetic vision loss.20 Yet, in this population, only 20% of diabetic persons have had an eye examination in the past year.21
Outreach clinics by visiting specialists have been shown to improve access to specialist services, including DR screening, for hard-to-reach populations.22,23 However, population-based DR screening is far more accessible if simple community-based screening facilities are routinely available. The need to bring the specialist to the patient in remote locations can be reduced for many types of health care, including screening for DR, using telemedicine technologies.24
A nonspecialist, community-based, outreach model for DR screening has emerged in which: (1) Photography is used instead of direct examination by a specialist clinician, and the image is then sent to a central specialist center. (2) The camera is operated by a photographer, technician, or health worker. (3) The pupil is generally not dilated (nonmydriatic), unlike direct ophthalmoscopic examination and other photographic methods, which require time-consuming and temporarily disabling pupil dilation. (4) The image is interpreted at a different place and time by an ophthalmologist or other trained reader.
This model has been applied in rural and/or remote areas of Australia25 and Canada,26 and for American Indian and Alaskan Native populations.27,28 For example, in the Kimberley region of northwestern Australia, local Aboriginal health care workers take retinal photographs that are subsequently interpreted by an ophthalmologist situated in Perth, 2000 km away.29 The outreach model has also been used in mobile vans in the United Kingdom.30
Outreach DR screening enables better coverage of at-risk populations, especially populations that are hard to reach.26 However, this carries the potential disadvantages of reductions in screening sensitivity (which would result in emergent cases of DR being missed) and specificity (creating undue referrals to costly specialist eye services). Our meta-analysis aimed to estimate the effect on screening accuracy of variations in mydriasis and in the medical qualifications of photographers, the 2 key characteristics of outreach screening methods that have the greatest potential effect on screening coverage.
We searched MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Cochrane Library, Rural and Remote Health Database (RURAL), and Indigenous Australia from their inception to June 2009. The search strategy comprised keywords for DR, DR-specific screening terms, and generic screening terms (Table 1). The reference lists of clinical guidelines and literature reviews (identified by searching these databases or already known by us) were searched for further relevant citations.
We included studies that aimed to evaluate the accuracy of a DR screening method among patients with diabetes or DR in which photography- or examination-based DR screening was compared with either 7-field mydriatic photography or dilated fundal examination by an ophthalmologist or equivalent specialist. Studies of automated analysis techniques and technologies were excluded because these are not currently standard practice. We included studies that measured sensitivity and specificity (widely accepted measures of a test's diagnostic accuracy31) to detect any DR, sight-threatening DR, or macular edema.
Two authors independently screened citations and full-text articles against inclusion criteria. Disagreements were resolved by consensus between these 2 authors or by adjudication from an ophthalmologist (H.R.T.).
Database items were developed in consultation with an experienced ophthalmologist (H.R.T.). Data extraction was performed by 2 authors and piloted using 10 included studies. Approximately 10% of data were audited, and appropriate corrections were made to the data and protocols.
We extracted data regarding country, region, and setting (specialist clinic, hospital, primary health care clinic, or outreach), number of patients and/or eyes in the sample, patient characteristics (percentage of men, age, and number of years with diabetes), prevalence of any DR in the sample, and the reference standard (7-field mydriatic photography or dilated fundal examination). Screening methods were categorized by screening instrument (film, Polaroid, or digital camera, direct examination, or scanning laser ophthalmoscope), mydriatic status (mydriasis, no mydriasis, mixed or not reported), number of photographic fields, medical qualifications of photographers (photographer or technician, nurse, general practitioner, or ophthalmologist), and qualifications of interpreter (general practitioner, ophthalmologist, optician, or grader).
For meta-analysis, screening methods were collapsed into 6 categories:
Nonmydriatic camera, nonspecialist photographer: nonmydriatic photography performed by a person with no specialist medical or eye qualifications (nurse, photographer, or technician).
Mydriatic camera, nonspecialist photographer: mydriatic photography performed by a person with no specialist medical or eye qualifications.
Nonmydriatic camera, specialist photographer: nonmydriatic photography performed by a trained health professional (general practitioner or diabetologist) or person with specialist eye qualifications (ophthalmologist, retinal specialist, or optometrist).
Mydriatic camera, specialist photographer: mydriatic photography performed by a trained health professional (general practitioner or diabetologist) or person with specialist eye qualifications (ophthalmologist, retinal specialist, or optometrist).
Direct examination: direct eye examination methods.
Other: for example, photographer not reported, mydriatic status mixed or not reported, or a combination of examination and photography.
Study characteristics were tabulated. Meta-analysis using Stata version 10.1 statistical software (StataCorp LP, College Station, Texas) determined sensitivity and specificity, adjusting for other characteristics of the studies and subjects. Forest plots portrayed sensitivity and specificity results of each included study. Owing to variations in the methods and reporting among studies, the unit of analysis was taken to be the number of patients rather than number of eyes. The quoted sensitivities and specificities in each article were then applied to the number of patients, producing a standard 2 × 2 table for each test within each article. Specificities of 100% were modified to enable analyses by reducing the number of true negatives by 1. We computed the 95% confidence intervals (CIs) in the forest plots using the Wilson score interval method.32
To account for multiple tests within each study and heterogeneity of sensitivity and specificity across studies, a 3-level random-intercepts logistic regression model33 using 20 numerical quadrature points was used, producing pooled estimates of sensitivity and specificity and 95% CIs (procedure xtmelogit in Stata version 10.1). This model accommodates heterogeneity in the sensitivity and specificity (on the logit scale) between studies and also between tests within the same study. Information concerning repeated measurement of subjects within the same study was not available; therefore, the logistic models assume that a different set of subjects was assessed for each test within each study.
Estimates of odds ratios (ORs) comparing sensitivity and specificity across subgroups were obtained by including the relevant covariate in the regression models. The small number of studies and tests within studies necessitated that all models assumed that the level of heterogeneity across studies and tests within studies were constant across subgroups. When the number of studies was very small and computational difficulties were encountered, the test-within-study variance component was omitted, and modeling proceeded using the between-study variance component only.
A flowchart of the search and selection of titles and abstracts is shown in Figure 1. Three hundred sixty-three titles and abstracts were identified; 188 potentially relevant full-text articles were evaluated; and 43 studies measured DR screening sensitivity and specificity. However, 22 different measures of DR were reported, using various permutations and combinations of DR classification levels. Only the category of “any DR” had sufficient consistency in definition, number of studies (n = 20), and number of sensitivity and specificity assessments (n = 40) for meta-analysis. The most common reason for exclusion of full-text articles was lack of comparison of screening method(s) with an accepted reference standard (n = 59).
Of the 20 included studies, 6 were conducted in the United Kingdom,34-39 5 in the United States,27,40-43 3 in Spain,44-46 and 1 each in Australia,47 Canada,26 Germany,48 Hong Kong,49 India,50 and the Netherlands51 (Table 2). Study settings were commonly diabetes clinics, primary health care facilities, and hospitals (4 studies each). The mean sample size was 207 patients (range, 14-773 patients). The mean age of study participants was 58.0 years (range, 48.0-68.8 years), and the mean percentage of male participants was 55.2% (range, 31.0%-98.4%). The mean duration of diabetes was 10.9 years (range, 3.7-17.7 years), and the mean prevalence of any DR was 46.0% (range, 9.0%-83.8%). Eleven studies contributed 1 assessment of a screening method; 4 studies contributed 2 screening assessments; 2 studies contributed 3 assessments; and 3 separate studies contributed 4, 5, and 6 assessments, respectively (Table 3).
The screening methods used were the use of a digital camera (17 assessments), the use of a film camera (8 assessments), direct examination (8 assessments), the use of a Polaroid camera (3 assessments), the use of various combinations of camera types or camera plus examination (3 assessments), and the use of a scanning laser ophthalmoscope (1 assessment) (Table 3). Pharmacological mydriasis was used in 23 assessments, no mydriasis was used in 12 assessments, a combination of mydriasis and no mydriasis was used in 4 assessments, and mydriatic status was not reported in 1 assessment. Of the methods involving imaging, single-field photography was most common (15 assessments), followed by 3-field photography (8 assessments) and 2-field photography (4 assessments).
Images were most frequently taken by a photographer or technician (12 assessments), general practitioner or physician (8 assessments), or nurse (3 assessments) and were most frequently interpreted by an ophthalmologist (16 assessments), trainee ophthalmologist (4 assessments), retinal specialist (4 assessments), or optometrist (4 assessments). Reference standards were dilated fundal examination (23 assessments), 7-field mydriatic photography (16 assessments), or both (1 assessment).
For statistical meta-analysis, 5 assessments were made using a nonmydriatic camera with a nonspecialist photographer; 8, mydriatic camera, nonspecialist photographer; 4, nonmydriatic camera, specialist photographer, 3, mydriatic camera, specialist photographer; 8, direct examination; and 12, the “other” category (eg, photographer not reported, mydriatic status mixed or not reported, or a combination of examination and photography).
Individual study estimates of sensitivity and specificity for detecting any DR are contained in the forest plots in Figures 2 and 3, respectively. The point estimates and 95% CIs are displayed, with screening assessments grouped by mydriatic status. For 2 studies,39,49 the lower limit of the 95% CI for sensitivity was less than 25% (Figure 2). Pooled estimates for sensitivity and specificity by mydriatic group and overall are also displayed in Figures 2 and 3. The pooled estimates for all included studies were 82.5% (95% CI, 75.6%-87.9%) and 88.4% (95% CI, 84.5%-91.4%) for sensitivity and specificity, respectively. The pooled sensitivity and specificity estimates for the 4 assessments that used a mix of nonmydriatic and mydriatic (ie, mydriasis as required) screening methods26,39,44 were 68.7% (95% CI, 43.4%-86.3%) and 89.0% (95% CI, 77.3%-95.1%), respectively.
Pooled estimates for various subgroups from the logistic regression models are presented in Table 4. All pooled estimates of sensitivity and specificity were greater than 80% except for the mydriatic status mixed or not reported category (sensitivity, 74.8%) and the direct examination category (sensitivity, 73.5% in photographer analysis and 73.9% in combination analysis). Variations in mydriatic status alone did not significantly influence sensitivity (OR, 0.89; 95% CI, 0.56-1.41; P = .61) or specificity (OR, 0.94; 95% CI, 0.57-1.54; P = .80) to detect any DR.
Variations in photographer medical qualification alone did not significantly influence sensitivity (P = .75) to detect any DR. The odds of a positive test result for diagnosing any DR when it was evident with the reference standard for photographers with specialist medical or eye qualifications were 1.25 times that of photographers without specialist medical or eye qualifications (95% CI, 0.31-5.12). For mydriatic camera methods, the OR was 1.61 (95% CI, 0.36-7.30; P = .54), and for nonmydriatic camera methods, the OR was 1.31 (95% CI, 0.30-5.66; P = .72).
The specificity of detection of any DR, however, was significantly higher for screening methods that use a photographer with specialist medical or eye qualifications (P = .001). When photographs were taken by photographers with specialist medical or eye qualifications, the odds of a negative screening test when DR was not evident with the reference standard were 3.86 times that when photographs were taken by photographers without specialist medical or eye qualifications (95% CI, 1.78-8.37). This was largely owing to the effect of specialists vs nonspecialists in photographs taken without mydriasis (OR, 5.65; 95% CI, 2.24-14.25; P < .001). For tests using mydriasis, although specificity was again greater for photographers with specialist medical or eye qualifications, this difference was not statistically significant (OR, 2.42; 95% CI, 0.86-6.84; P = .09). One study46 yielded 6 of the 7 assessments in the “specialist” category.
In our meta-analysis of 40 assessments of 20 studies from 9 countries, sensitivity to detect any DR was not influenced by variations in mydriatic status or photographer medical qualifications, either alone or in combination. Therefore, retinal photography by a photographer with no specialist medical or eye qualifications (ie, a health worker or nurse), without using pupil-dilating eye drops (the outreach model), appears unlikely to miss cases of DR that screening methods using mydriasis or a photographer with specialist medical or eye qualifications would detect.
Improving screening coverage can prevent blindness due to DR and reduce overall health care costs; mathematical modeling demonstrates that increasing screening coverage from 30% to 80% in Australia would reduce the overall health care cost of DR and its consequences from approximately $193 million to $178 million per year.52 The relative benefit is likely much greater in rural and remote areas where specialist resources are scarce and diabetes prevalence is proportionally higher.
Most guidelines recommend annual screening of patients with diabetes.13,53 Javitt et al54 modeled the relationship between screening sensitivity and person-years of sight saved for annual screening and found that sensitivity values greater than 60% do not substantially add to person-years of sight saved or reduce screening costs. Javitt et al hypothesized that the diminishing additional benefit of sensitivity values greater than 60% was owing to the frequency of screening and the likelihood that DR cases missed on one visit will be detected on the next. In our meta-analysis, the pooled estimates for sensitivity to detect any DR for all image-based screening methods, regardless of mydriatic status and photographer medical qualifications, were greater than 80%.
We found that screening involving photographers without specialist medical or eye qualifications yielded significantly lower specificity (ie, a greater false positive rate) than screening involving photographers with specialist medical or eye qualifications, particularly when mydriasis was not used. This finding should be interpreted in the context that 1 study46 yielded 6 of the 7 assessments in the specialist category. The greater number of false positives found when photographers without specialist medical or eye qualifications were used may be owing to imaging difficulties or poorer image quality in their photographs, especially when the pupil is not dilated. The result may be a referral to an eye specialist for further examination. In addition to inconveniencing patients, unnecessary referrals place a burden on limited ophthalmological infrastructure and personnel. Although false positives may be less harmful than missing DR and the opportunity to prevent vision loss, they may offset some of the economic advantages of outreach screening methods.
Only 4 assessments from 3 studies followed a mixed strategy of using mydriasis when required to obtain a better image. This is potentially a pragmatic, “best of both worlds” approach in which the time delay and discomfort of mydriasis is mostly avoided without compromising sensitivity and specificity. The pooled sensitivity estimate for these studies (68.7%) was lower than for other categories, although it still exceeded the threshold reported in Javitt et al,54 and the specificity for mixed mydriasis (88.8%) was comparable with that of other screening methods. Further research is required to gain a more robust picture of the accuracy of this approach.
Although we considered studies that examined accuracy of detection of all degrees of retinopathy, we were only able to analyze studies of screening to detect any DR. There was too much variation in other categories of DR and too few assessments in any 1 category. Future studies of DR screening accuracy should use a consistent DR classification scheme, such as that of the International Clinical Diabetic Retinopathy Disease Severity Scale.55 This scale was designed to enable clinically important DR grades to be identified by less experienced screeners, therefore improving communication between the various health professions involved in DR screening.4 It also specifies the equivalence of the most frequently used DR classification scale (ie, the Early Treatment of Diabetic Retinopathy Severity Scale) to the International Clinical Diabetic Retinopathy Disease Severity Scale.
Furthermore, 12 assessments from 9 studies had to be classified as “other” for analysis purposes. In 7 assessments, this was because details of the photographer could not be ascertained. Better reporting of such details of DR screening methods, combined with a consistent approach to DR classification, would enable a greater range of measures in DR screening studies to be meaningfully compared and analyzed.
This meta-analysis found that outreach DR screening is an effective alternative to screening that uses mydriasis or a medical specialist photographer. The outreach model has enormous potential to increase the screening coverage of at-risk populations in areas of the world where specialist ophthalmic resources are limited and to be a cost-effective way of preventing blindness among diabetics. Outreach DR screening could therefore contribute substantially to the Vision 2020 objective of setting up systems to prevent DR-related vision loss in high-risk countries, “taking into account the country's resources, social expectations and health-care infrastructure.”13
Correspondence: Hugh R. Taylor, MD, Melbourne School of Population Health, University of Melbourne, Level 5, 207 Bouverie St, Carlton, Melbourne, Victoria 3053, Australia (h.taylor@unimelb.edu.au).
Submitted for Publication: March 4, 2010; final revision received September 12, 2010; accepted September 15, 2010.
Published Online: December 13, 2010. doi:10.1001/archophthalmol.2010.319
Financial Disclosure: None reported.
Funding/Support: This study was supported by funding from the Harold Mitchell Foundation, the Ian Potter Foundation, and the Cybec Foundation; and a National Health and Medical Research Council Career Development Award (Prof Gruen).
Role of the Sponsor: The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.
Additional Contributions: We thank Anne Parkhill, MBIT, DipLib, from Aptly Information Design for developing the search strategy, Jason Wasiak, MPH, from Monash University, Alfred Hospital, for his contribution to study selection, and Ornella Clavisi, MPH, BSc(Hons) from Monash University and Alex Hewitt, MD, PhD, from the Royal Victorian Eye and Ear Hospital, and Nathalie Colomer, MD, from Pontificia Universidad Católica de Chile for their contribution to the data extraction protocol design. Anne Parkhill received financial compensation for her contribution to this manuscript.
1.Wild
SRoglic
GGreen
ASicree
RKing
H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
Diabetes Care 2004;27
(5)
1047- 1053
PubMedGoogle ScholarCrossref 2.Resnikoff
SPascolini
DEtya’ale
D
et al. Global data on visual impairment in the year 2002.
Bull World Health Organ 2004;82
(11)
844- 851
PubMedGoogle Scholar 4.National Health and Medical Research Council, Guidelines for the Management of Diabetic Retinopathy. Canberra, Australia Commonwealth of Australia2008;
5.Williams
RAirey
MBaxter
HForrester
JKennedy-Martin
TGirach
A Epidemiology of diabetic retinopathy and macular oedema: a systematic review.
Eye (Lond) 2004;18
(10)
963- 983
PubMedGoogle ScholarCrossref 6.Office for Aboriginal and Torres Strait Islander Health, Specialist Eye Health Guidelines for Use in Aboriginal and Torres Strait Islander Populations: Cataract, Diabetic Retinopathy, Trachoma. Canberra, Australia Dept of Health and Aged Care, Commonwealth of Australia2001;
7.Klein
RKlein
BEMoss
SEDavis
MDDeMets
DL The Wisconsin epidemiologic study of diabetic retinopathy, II: prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.
Arch Ophthalmol 1984;102
(4)
520- 526
PubMedGoogle ScholarCrossref 8.Lim
AStewart
JChui
TY
et al. Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population.
Ophthalmic Epidemiol 2008;15
(6)
402- 409
PubMedGoogle ScholarCrossref 9.The Diabetic Retinopathy Study Research Group, Photocoagulation treatment of proliferative diabetic retinopathy; clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8.
Ophthalmology 1981;88
(7)
583- 600
PubMedGoogle ScholarCrossref 10.Early Treatment Diabetic Retinopathy Study Research Group, Early photocoagulation for diabetic retinopathy: ETDRS report number 9.
Ophthalmology 1991;98
(5)
((suppl))
766- 785
PubMedGoogle ScholarCrossref 12.Fong
DSAiello
LGardner
TW
et al. American Diabetes Association, Retinopathy in diabetes.
Diabetes Care 2004;27
((suppl 1))
S84- S87
PubMedGoogle ScholarCrossref 13.World Health Organization, Vision 2020: The Right to Sight: Global Initiative for the Elimination of Avoidable Blindness: Action Plan 2006-2011. Paris, France World Health Organization2007;
14. McKay
R McCarty
CATaylor
HR Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project.
Br J Ophthalmol 2000;84
(8)
865- 870
PubMedGoogle ScholarCrossref 15.Lee
PPFeldman
ZWOstermann
JBrown
DSSloan
FA Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases.
Ophthalmology 2003;110
(10)
1952- 1959
PubMedGoogle ScholarCrossref 16.Soto-Pedre
EHernaez-Ortega
MC Screening coverage for diabetic retinopathy using a three-field digital non-mydriatic fundus camera.
Prim Care Diabetes 2008;2
(3)
141- 146
PubMedGoogle ScholarCrossref 17.Taylor
CRMerin
LMSalunga
AM
et al. Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology: the Vine Hill Study.
Diabetes Care 2007;30
(3)
574- 578
PubMedGoogle ScholarCrossref 18.Leese
GPAhmed
SNewton
RW
et al. Use of mobile screening unit for diabetic retinopathy in rural and urban areas.
BMJ 1993;306
(6871)
187- 189
PubMedGoogle ScholarCrossref 19.Taylor
RBritish Diabetic Association Mobile Retinal Screening Group, Practical community screening for diabetic retinopathy using the mobile retinal camera: report of a 12 centre study.
Diabet Med 1996;13
(11)
946- 952
PubMedGoogle ScholarCrossref 20.Taylor
HRNational Indigenous Eye Health Survey Team, National Indigenous Eye Health Survey. Melbourne, Australia Indigenous Eye Health Unit, Melbourne School of Population Health, University of Melbourne2009;
21.Taylor
HRXie
JFox
SDunn
RAArnold
ALKeeffe
JE The prevalence and causes of vision loss in Indigenous Australians: the National Indigenous Eye Health Survey.
Med J Aust 2010;192
(6)
312- 318
PubMedGoogle Scholar 22.Gruen
RLWeeramanthri
TSKnight
SEBailie
RS Specialist outreach clinics in primary care and rural hospital settings.
Cochrane Database Syst Rev 2004;
(1)
CD003798
PubMedGoogle Scholar 23.Gruen
RLBailie
RSWang
ZHeard
SO’Rourke
IC Specialist outreach to isolated and disadvantaged communities: a population-based study.
Lancet 2006;368
(9530)
130- 138
PubMedGoogle ScholarCrossref 24.Nathoo
NNg
MRudnisky
CJTennant
MT The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta.
Can J Ophthalmol 2010;45
(1)
28- 32
PubMedGoogle ScholarCrossref 25.Harper
CALivingston
PMWood
C
et al. Screening for diabetic retinopathy using a non-mydriatic retinal camera in rural Victoria.
Aust N Z J Ophthalmol 1998;26
(2)
117- 121
PubMedGoogle ScholarCrossref 26.Maberley
DCruess
AFBarile
GSlakter
J Digital photographic screening for diabetic retinopathy in the James Bay Cree.
Ophthalmic Epidemiol 2002;9
(3)
169- 178
PubMedGoogle ScholarCrossref 27.Bursell
SECavallerano
JDCavallerano
AA
et al. Joslin Vision Network Research Team, Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy.
Ophthalmology 2001;108
(3)
572- 585
PubMedGoogle ScholarCrossref 29.Murray
RBMetcalf
SMLewis
PMMein
JK McAllister
IL Sustaining remote-area programs: retinal camera use by Aboriginal health workers and nurses in a Kimberley partnership.
Med J Aust 2005;182
(10)
520- 523
PubMedGoogle Scholar 30.Leese
GPNewton
RWJung
RTHaining
WEllingford
A Screening for diabetic retinopathy in a widely spaced population using non-mydriatic fundus photography in a mobile unit: Tayside Mobile Eye Screening Unit.
Diabet Med 1992;9
(5)
459- 462
PubMedGoogle ScholarCrossref 31.Jones
CMAthanasiou
T Diagnostic accuracy meta-analysis: review of an important tool in radiological research and decision making.
Br J Radiol 2009;82
(978)
441- 446
PubMedGoogle ScholarCrossref 32.Newcombe
RG Two-sided confidence intervals for the single proportion: comparison of seven methods.
Stat Med 1998;17
(8)
857- 872
PubMedGoogle ScholarCrossref 33.Skrondal
ARabe-Hesketh
S Generalized Latent Variable Modeling: Multilevel, Longitudinal and Structural Equation Models. Boca Raton, FL Chapman & Hall/CRC Press2004;
34.Williams
RNussey
SHumphry
RThompson
G Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy.
BMJ (Clin Res Ed) 1986;293
(6555)
1140- 1142
Google ScholarCrossref 35.Taylor
DJFisher
JJacob
JTooke
JE The use of digital cameras in a mobile retinal screening environment.
Diabet Med 1999;16
(8)
680- 686
PubMedGoogle ScholarCrossref 36.Hulme
SATin-U
AHardy
KJJoyce
PW Evaluation of a district-wide screening programme for diabetic retinopathy utilizing trained optometrists using slit-lamp and Volk lenses.
Diabet Med 2002;19
(9)
741- 745
PubMedGoogle ScholarCrossref 37.Olson
JAStrachan
FMHipwell
JH
et al. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy.
Diabet Med 2003;20
(7)
528- 534
PubMedGoogle ScholarCrossref 38.Murgatroyd
HEllingford
ACox
A
et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease.
Br J Ophthalmol 2004;88
(7)
920- 924
Google ScholarCrossref 39.Herbert
HMJordan
KFlanagan
DW Is screening with digital imaging using one retinal view adequate?
Eye (Lond) 2003;17
(4)
497- 500
PubMedGoogle ScholarCrossref 40.Peters
ALDavidson
MBZiel
FH Cost-effective screening for diabetic retinopathy using a nonmydriatic retinal camera in a prepaid health-care setting.
Diabetes Care 1993;16
(8)
1193- 1195
PubMedGoogle ScholarCrossref 41.Lawrence
MG The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards.
Trans Am Ophthalmol Soc 2004;102321- 340
PubMedGoogle Scholar 42.Kleinstein
RNRoseman
JMHerman
WHHolcombe
JLouv
WC Detection of diabetic retinopathy by optometrists.
J Am Optom Assoc 1987;58
(11)
879- 882
PubMedGoogle Scholar 43.Friberg
TRPandya
AEller
AW Non-mydriatic panoramic fundus imaging using a non-contact scanning laser-based system.
Ophthalmic Surg Lasers Imaging 2003;34
(6)
488- 497
Google Scholar 44.Molina Fernández
EValero Moll
MSPedregal González
M
et al. Validation of the electronic mailing of retinographs of diabetic patients in order to detect retinopathy in primary care [in Spanish].
Aten Primaria 2008;40
(3)
119- 123
PubMedGoogle ScholarCrossref 45.Lopez-Bastida
JCabrera-Lopez
FSerrano-Aguilar
P Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy.
Diabet Med 2007;24
(4)
403- 407
Google ScholarCrossref 46.Baeza
MOrozco-Beltrán
DGil-Guillen
VF
et al. Screening for sight threatening diabetic retinopathy using non-mydriatic retinal camera in a primary care setting: to dilate or not to dilate?
Int J Clin Pract 2009;63
(3)
433- 438
PubMedGoogle ScholarCrossref 47.Schmid
KLSwann
PGPedersen
CSchmid
LM The detection of diabetic retinopathy by Australian optometrists.
Clin Exp Optom 2002;85
(4)
221- 228
PubMedGoogle ScholarCrossref 48.Neubauer
ASRothschuh
AUlbig
MWBlum
M Digital fundus image grading with the non-mydriatic Visucam(PRO NM) versus the FF450(plus) camera in diabetic retinopathy.
Acta Ophthalmol (Copenh) 2008;86
(2)
177- 182
Google ScholarCrossref 49.Siu
SCKo
TCWong
KWChan
WN Effectiveness of non-mydriatic retinal photography and direct ophthalmoscopy in detecting diabetic retinopathy.
Hong Kong Med J 1998;4
(4)
367- 370
PubMedGoogle Scholar 50.Verma
LPrakash
GTewari
HKGupta
SKMurthy
GVSharma
N Screening for diabetic retinopathy by non-ophthalmologists: an effective public health tool.
Acta Ophthalmol Scand 2003;81
(4)
373- 377
PubMedGoogle ScholarCrossref 51.Reenders
Kde Nobel
Evan den Hoogen
Hvan Weel
C Screening for diabetic retinopathy by general practitioners.
Scand J Prim Health Care 1992;10
(4)
306- 309
PubMedGoogle ScholarCrossref 52.National Health and Medical Research Council, Clinical Practice Guidelines: Management of Diabetic Retinopathy. Canberra, Australia Commonwealth Dept of Health and Family Services1997;
53.American Academy of Ophthalmology Retina Panel, Preferred Practice Pattern Guidelines: Diabetic Retinopathy. San Francisco, CA American Academy of Ophthalmology2008;
54.Javitt
JCCanner
JKFrank
RGSteinwachs
DMSommer
A Detecting and treating retinopathy in patients with type I diabetes mellitus: a health policy model.
Ophthalmology 1990;97
(4)
483- 495
PubMedGoogle ScholarCrossref